Will the new 15-minute COVID-19 test solve US testing problems?

The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.

Zoë McLaren, Associate Professor of Public Policy, University of Maryland, Baltimore County • conversation
Sept. 1, 2020 ~6 min

Rapid screening tests that prioritize speed over accuracy could be key to ending the coronavirus pandemic

Testing large numbers of people regularly would reduce the spread of the coronavirus in the US. Laboratory testing is slow and expensive, but rapid screening tests could be the answer.

Zoë McLaren, Associate Professor of Public Policy, University of Maryland, Baltimore County • conversation
Aug. 14, 2020 ~9 min

Could pressure for COVID-19 drugs lead the FDA to lower its standards?

The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?

Leigh Turner, Associate Professor, University of Minnesota Center for Bioethics, School of Public Health, & College of Pharmacy, University of Minnesota • conversation
June 10, 2020 ~10 min

What needs to go right to get a coronavirus vaccine in 12-18 months

Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.

Marcos E. García-Ojeda, Professor of Molecular and Cell Biology, University of California, Merced • conversation
May 8, 2020 ~10 min

/

1